Letrozole Tablets USP 2.5 mg
$50.00 – $180.00Price range: $50.00 through $180.00
SKU : N/A
Category : Other
Letrozole Tablets USP 2.5 mg contains letrozole, an aromatase inhibitor used under medical supervision to manage hormone-dependent breast cancer by reducing estrogen levels.
Product Overview
Letrozole Tablets USP 2.5 mg is a prescription medication primarily used in the management of hormone-dependent conditions, most notably certain types of breast cancer in postmenopausal women. It belongs to a class of medicines known as aromatase inhibitors. This medication is commonly prescribed as part of long-term treatment plans under the supervision of a qualified healthcare professional. Letrozole is intended for patients where reducing estrogen levels is clinically beneficial and is used according to established medical guidelines.
How It Works
Letrozole works by inhibiting the action of an enzyme called aromatase. Aromatase is responsible for converting androgens into estrogen in the body, particularly in postmenopausal women. By blocking this enzyme, Letrozole significantly reduces estrogen production. Since some hormone-sensitive cancers rely on estrogen to grow and spread, lowering estrogen levels can help slow or prevent disease progression. The mechanism is systemic and targeted, making Letrozole effective in conditions where estrogen suppression is required.
Uses / Indications
Letrozole Tablets USP 2.5 mg is primarily indicated for:
-
Treatment of hormone receptor-positive breast cancer in postmenopausal women
-
Extended adjuvant therapy following initial cancer treatment
-
Management of advanced or metastatic breast cancer when hormone therapy is appropriate
In some clinical settings, Letrozole may also be prescribed for other estrogen-related conditions based on a physician’s assessment. All uses should follow evidence-based medical practice and regulatory approvals.
Composition
Each tablet contains Letrozole as the active pharmaceutical ingredient. The medication is formulated as an oral tablet for systemic absorption. Inactive excipients are included to ensure tablet stability, consistency, and proper absorption but do not contribute to the therapeutic effect. Letrozole Tablets USP 2.5 mg conforms to United States Pharmacopeia (USP) quality standards.
Administration
Letrozole Tablets are administered orally and should be taken exactly as prescribed by a healthcare professional. The tablet is usually taken once daily, with or without food, depending on clinical advice. Treatment duration and monitoring are determined by the physician based on the patient’s condition, response to therapy, and overall health status. Patients should not alter or discontinue the medication without consulting their healthcare provider.
Storage Instructions
Store Letrozole Tablets at room temperature, away from excess heat, moisture, and direct sunlight. Keep the tablets in their original packaging until use to maintain product integrity. Ensure the medication is kept out of reach of children and pets.
Important Information / Warning
Letrozole Tablets USP 2.5 mg should be used only under strict medical supervision. It is intended for postmenopausal women and is not recommended for use during pregnancy or breastfeeding due to potential risks to the fetus or infant. Patients with liver impairment, bone density concerns, or cardiovascular conditions should inform their healthcare provider before starting treatment. Regular medical follow-up, including laboratory tests and clinical evaluations, may be required to monitor therapy safety and effectiveness. Report any unusual symptoms or side effects to a healthcare professional promptly.
For additional patient-friendly medical information, you may refer to MedlinePlus – Letrozole, a trusted resource provided by the U.S. National Library of Medicine:
https://medlineplus.gov/druginfo/meds/a602018.html
| Pack Size |
100 Tablets ,150 Tablets ,200 Tablets ,300 Tablets ,50 Tablets |
|---|

